Earlier this week, Select Medical Holdings Corporation (NYSE: SEM) announced that it had signed a definitive agreement to be acquired by an investor consortium led by Robert Ortenzio, Martin Jackson, and Welsh, Carson, Anderson & Stowe (WCAS). The take-private transaction values Select Medical at $16.50 per share, representing an enterprise value of approximately $3.9 billion. The offer reflects a ~25% premium to the 90-day trading average and a modest premium to the non-binding proposal submitted by Robert Ortenzio in November 2025. At first glance, this appears to be a straightforward public-to-private transaction. The more interesting story is what this deal could enable strategically.
Read the full article: Select Medical Goes Private (Again) – The Bigger Story May Be What’s Next //
Source: https://livingstonepartners.com/en-us/insights/select-medical-goes-private-again-the-bigger-story-may-be-whats-next/